To explore the underlying mechanisms regulating the effects of Icaritin on RCC cells, we examined several major oncogenic signaling pathways, including STAT3, AKT, and mitogen-activated protein kinase (MAPK) [14], [40], [41]. This evidence concerns the gene AKT1 and renal cell carcinoma.